Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

TLV:REKA Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.03	19.31	20.21	18.6	36.89
Trading Asset Securities	0.04	0.04	0.08	0.04	0.04
Cash & Short-Term Investments	7.07	19.35	20.29	18.64	36.93
Cash Growth	-63.48%	-4.63%	8.83%	-49.53%	44.22%
Accounts Receivable	127.11	117.68	120.71	107.37	87.63
Other Receivables	8.55	8.67	6.83	2.25	1.98
Receivables	135.66	126.35	127.54	109.62	89.61
Inventory	82.48	96.6	92.2	89.61	97.85
Prepaid Expenses	2.63	1.94	1.83	1.42	0.71
Other Current Assets	1.22	7.09	1.28	2.37	2.25
Total Current Assets	229.05	251.33	243.14	221.66	227.35
Property, Plant & Equipment	140.07	154.62	163.21	177	181.82
Long-Term Investments	1.18	1.17	-	-	1.84
Goodwill	35.14	35.14	15.18	-	-
Other Intangible Assets	25.7	31.66	20.67	32.97	4.18
Long-Term Deferred Tax Assets	16.07	10.79	6.22	5.46	4.5
Other Long-Term Assets	-	0.01	0.01	0.01	0.01
Total Assets	447.22	484.72	448.42	437.09	419.69
Accounts Payable	87.52	78.89	81.21	57.44	59.89
Accrued Expenses	20.98	23.95	17.05	13.61	12.96
Short-Term Debt	14.35	3.12	-	0.01	5
Current Portion of Long-Term Debt	15.2	24.8	30.9	18.96	22.06
Current Portion of Leases	7.29	6.9	5.59	5.03	4.82
Current Income Taxes Payable	0.35	1.56	0.76	0.26	0.96
Current Unearned Revenue	0.24	0.13	0.1	0.25	0.88
Other Current Liabilities	12.13	4.45	3.44	3.04	1.7
Total Current Liabilities	158.04	143.79	139.03	98.61	108.26
Long-Term Debt	63.62	110.09	91.66	101.23	90.86
Long-Term Leases	33.7	38.76	37.55	40.6	43.6
Long-Term Deferred Tax Liabilities	5.27	6.03	2.75	3.16	-
Other Long-Term Liabilities	14.02	20.74	6.49	11.21	2
Total Liabilities	285.24	329.14	286.34	264.03	254.1
Common Stock	13.64	13.64	13.64	13.64	13.64
Additional Paid-In Capital	126.61	126.61	126.61	126.61	126.61
Retained Earnings	21.19	14.67	21.35	32.73	25.69
Treasury Stock	-0.51	-0.51	-0.51	-0.51	-0.51
Comprehensive Income & Other	0.99	1.12	0.93	0.54	0.09
Total Common Equity	161.93	155.54	162.03	173.01	165.53
Minority Interest	0.05	0.05	0.05	0.05	0.06
Shareholders' Equity	161.98	155.59	162.08	173.07	165.59
Total Liabilities & Equity	447.22	484.72	448.42	437.09	419.69
Total Debt	134.16	183.66	165.7	165.82	166.34
Net Cash (Debt)	-127.09	-164.31	-145.41	-147.18	-129.41
Net Cash Per Share	-11.13	-14.39	-12.74	-12.89	-11.34
Filing Date Shares Outstanding	11.41	11.41	11.41	11.41	11.41
Total Common Shares Outstanding	11.41	11.41	11.41	11.41	11.41
Working Capital	71.01	107.54	104.11	123.05	119.09
Book Value Per Share	14.19	13.63	14.19	15.16	14.50
Tangible Book Value	101.09	88.73	126.18	140.05	161.35
Tangible Book Value Per Share	8.86	7.77	11.05	12.27	14.14
Land	1.89	1.89	2.07	2.07	2.07
Buildings	119.29	117.94	124.71	122.66	119.21
Machinery	125.12	121.03	112.99	109.84	106.6
Leasehold Improvements	63.16	61.15	58.28	57.23	54.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.